Rapid cycling bipolar affective disorder in people with intellectual disability: a systematic review.

Konstantareas et al. (1999) hunted every paper they could find on rapid-cycling bipolar disorder in people with intellectual disability. They read case reports, small trials, and clinic notes. The goal was to see how this mood illness looks and responds to drugs when it shows up in clients who already have ID.

Only a handful of usable papers existed. The picture that emerged: more males than females, mood swings starting younger, and lithium often failing to help. Doctors were already using other mood drugs, but proof was thin.

Craddock et al. (1994) thought Down syndrome might shield people from bipolar disorder. Konstantareas et al. (1999) still found rapid-cycling cases in the wider ID group. The gap is explained by genetics: Down syndrome is only one cause of ID, so protection there does not cancel bipolar risk in other forms.

Lecavalier et al. (2006) later showed adults with ID plus bipolar speak more harsh words than matched peers. This adds detail M et al. could not give, because their data were too sparse.

Rojahn et al. (1994) surveyed clients and carers on lithium and found most liked the drug. M et al. warn the same drug may not work for rapid-cycling in ID, so liking does not equal benefit.

If you serve adults with ID who swing from high energy to deep sadness within days, do not count on lithium alone. Ask the doctor about second-line mood stabilizers such as valproate or aripiprazole. Track mood daily with simple 3-point scales the client can point to. Share your data at psychiatry visits so dose changes are based on behavior, not memory.